135 related articles for article (PubMed ID: 11743172)
21. A novel transgenic mouse model produced from lentiviral germline integration for the study of beta-thalassemia gene therapy.
Li W; Xie S; Guo X; Gong X; Wang S; Lin D; Zhang J; Ren Z; Huang S; Zeng F; Zeng Y
Haematologica; 2008 Mar; 93(3):356-62. PubMed ID: 18268280
[TBL] [Abstract][Full Text] [Related]
22. RISC control for gene therapy.
Qasim W; Thrasher AJ
Nat Biotechnol; 2006 Jun; 24(6):661-2. PubMed ID: 16763596
[No Abstract] [Full Text] [Related]
23. Optimization of equine infectious anemia derived vectors for hematopoietic cell lineage gene transfer.
O'Rourke JP; Olsen JC; Bunnell BA
Gene Ther; 2005 Jan; 12(1):22-9. PubMed ID: 15550928
[TBL] [Abstract][Full Text] [Related]
24. Chronic physical activity limits blood rheology alterations in transgenic SAD mice.
Faes C; Charrin E; Connes P; Pialoux V; Martin C
Am J Hematol; 2015 Feb; 90(2):E32-3. PubMed ID: 25382738
[No Abstract] [Full Text] [Related]
25. Targeted beta-globin gene conversion in human hematopoietic CD34(+ )and Lin(-)CD38(-)cells.
Liu H; Agarwal S; Kmiec E; Davis BR
Gene Ther; 2002 Jan; 9(2):118-26. PubMed ID: 11857070
[TBL] [Abstract][Full Text] [Related]
26. Regulatory elements of the vav gene drive transgene expression in hematopoietic stem cells from adult mice.
Almarza E; Segovia JC; Guenechea G; Gómez SG; Ramírez A; Bueren JA
Exp Hematol; 2004 Apr; 32(4):360-4. PubMed ID: 15050746
[TBL] [Abstract][Full Text] [Related]
27. Third strand-mediated psoralen-induced correction of the sickle cell mutation on a plasmid transfected into COS-7 cells.
Varganov Y; Amosova O; Fresco JR
Gene Ther; 2007 Jan; 14(2):173-9. PubMed ID: 16943853
[TBL] [Abstract][Full Text] [Related]
28. Lineage-specific activators affect beta-globin locus chromatin in multipotent hematopoietic progenitors.
Bottardi S; Ross J; Pierre-Charles N; Blank V; Milot E
EMBO J; 2006 Aug; 25(15):3586-95. PubMed ID: 16858401
[TBL] [Abstract][Full Text] [Related]
29. Sickle cell and silent spleen.
Tolar J
Blood; 2015 Apr; 125(17):2589-90. PubMed ID: 25907900
[TBL] [Abstract][Full Text] [Related]
30. Gene replacement therapy for sickle cell disease and other blood disorders.
Townes TM
Hematology Am Soc Hematol Educ Program; 2008; ():193-6. PubMed ID: 19074080
[TBL] [Abstract][Full Text] [Related]
31. [Advances in sickle cell disease].
de Montalembert M
Bull Acad Natl Med; 2008 Oct; 192(7):1375-81; discussion 1381. PubMed ID: 19445363
[TBL] [Abstract][Full Text] [Related]
32. Restoration of the balanced alpha/beta-globin gene expression in beta654-thalassemia mice using combined RNAi and antisense RNA approach.
Xie SY; Ren ZR; Zhang JZ; Guo XB; Wang QX; Wang S; Lin D; Gong XL; Li W; Huang SZ; Zeng F; Zeng YT
Hum Mol Genet; 2007 Nov; 16(21):2616-25. PubMed ID: 17716993
[TBL] [Abstract][Full Text] [Related]
33. Mouse models of sickle cell disease.
Beuzard Y
Transfus Clin Biol; 2008; 15(1-2):7-11. PubMed ID: 18502677
[TBL] [Abstract][Full Text] [Related]
34. Stem cell transplantation demonstrates that Sox6 represses epsilon y globin expression in definitive erythropoiesis of adult mice.
Cohen-Barak O; Erickson DT; Badowski MS; Fuchs DA; Klassen CL; Harris DT; Brilliant MH
Exp Hematol; 2007 Mar; 35(3):358-67. PubMed ID: 17309816
[TBL] [Abstract][Full Text] [Related]
35. Instant conditional transgenesis in the mouse hematopoietic compartment.
Csikós T; Reijmers RM; Uren AG; Spaargaren M; Pals ST
J Immunol Methods; 2008 Dec; 339(2):259-63. PubMed ID: 18793641
[TBL] [Abstract][Full Text] [Related]
36. Advances in the management of sickle cell disease.
Thompson AA
Pediatr Blood Cancer; 2006 May; 46(5):533-9. PubMed ID: 16261589
[TBL] [Abstract][Full Text] [Related]
37. Pathophysiology and therapy for haemoglobinopathies. Part I: sickle cell disease.
Madigan C; Malik P
Expert Rev Mol Med; 2006 Apr; 8(9):1-23. PubMed ID: 16690007
[TBL] [Abstract][Full Text] [Related]
38. Expression from second-generation feline immunodeficiency virus vectors is impaired in human hematopoietic cells.
Price MA; Case SS; Carbonaro DA; Yu XJ; Petersen D; Sabo KM; Curran MA; Engel BC; Margarian H; Abkowitz JL; Nolan GP; Kohn DB; Crooks GM
Mol Ther; 2002 Nov; 6(5):645-52. PubMed ID: 12409263
[TBL] [Abstract][Full Text] [Related]
39. Genetic strategies for the treatment of sickle cell anaemia.
Mansilla-Soto J; Rivière I; Sadelain M
Br J Haematol; 2011 Sep; 154(6):715-27. PubMed ID: 21707580
[TBL] [Abstract][Full Text] [Related]
40. The first steps on the gene therapy pathway to anti-sickling success.
Karlsson S
Nat Med; 2000 Feb; 6(2):139-40. PubMed ID: 10655097
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
